Cell & Gene Therapy

The rise of Cell & Gene Therapy and other Advanced Therapy Medicinal Products (ATMP) heralds a new era in healthcare. The ability to target DNA or RNA inside or outside the body and potentially modify genetic material to provide the antibodies needed to fight diseases has created an increased interest in how this technology can be manufactured and commercialised. Especially when ATMPs are so patient centric and delivered at such a high cost.

Scitech’s team of bioprocess engineers, process architects and engineering designers address these challenges by focusing on Good Manufacturing Practice (GMP). The team is able to deliver and oversee every stage of the project to ensure everything from the design of a facility to the selection of hardware and software is geared towards meeting all regulations and built to be scalable. With a focus in the biological sector, Scitech has built a team of thought leaders and industry experts that deliver tailored projects that are compliant, cost effective and flexible.